Conneqt Health Limited is an Australian health technology company specializing in the design, manufacture, and marketing of medical devices for cardiovascular health management. The company’s flagship technology, SphygmoCor, enables noninvasive measurement of central hemodynamics and arterial stiffness, providing critical vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders. Conneqt Health’s product suite includes advanced devices such as CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor, which are used by hospitals, clinics, research institutions, and pharmaceutical companies across the Americas, Europe, and the Asia Pacific. The company also develops digital solutions, wearables, and remote patient monitoring platforms, supporting decentralized clinical trials and home health applications. Listed on the CHI-X Market Australia – Limit Venue, Conneqt Health plays a role in advancing cardiovascular diagnostics and patient care through innovative medical technology.